Monsanto Company (MON) Shares Sold by Dividend Assets Capital LLC
Dividend Assets Capital LLC trimmed its holdings in Monsanto Company (NYSE:MON) by 4.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 343,598 shares of the company’s stock after selling 16,998 shares during the period. Monsanto comprises about 1.7% of Dividend Assets Capital LLC’s investment portfolio, making the stock its 23rd largest holding. Dividend Assets Capital LLC owned about 0.08% of Monsanto worth $41,170,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of the company. Puplava Financial Services Inc. boosted its position in shares of Monsanto by 0.4% during the second quarter. Puplava Financial Services Inc. now owns 2,119 shares of the company’s stock worth $251,000 after buying an additional 9 shares during the period. Guardian Life Insurance Co. of America boosted its position in shares of Monsanto by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 1,689 shares of the company’s stock worth $191,000 after buying an additional 11 shares during the period. Enterprise Financial Services Corp boosted its position in shares of Monsanto by 1.2% during the second quarter. Enterprise Financial Services Corp now owns 1,384 shares of the company’s stock worth $164,000 after buying an additional 16 shares during the period. Forward Management LLC boosted its position in shares of Monsanto by 0.5% during the second quarter. Forward Management LLC now owns 3,201 shares of the company’s stock worth $379,000 after buying an additional 16 shares during the period. Finally, Lee Financial Co boosted its position in shares of Monsanto by 0.3% during the second quarter. Lee Financial Co now owns 6,067 shares of the company’s stock worth $718,000 after buying an additional 17 shares during the period. 74.50% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another website, it was copied illegally and reposted in violation of US and international trademark and copyright legislation. The original version of this piece of content can be read at https://www.thecerbatgem.com/2017/11/13/monsanto-company-mon-shares-sold-by-dividend-assets-capital-llc.html.
In other Monsanto news, VP Duraiswami Narain sold 2,860 shares of the company’s stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $120.00, for a total value of $343,200.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, COO Brett D. Begemann sold 22,640 shares of the stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $120.03, for a total value of $2,717,479.20. Following the transaction, the chief operating officer now owns 85,439 shares in the company, valued at approximately $10,255,243.17. The disclosure for this sale can be found here. Insiders sold 49,236 shares of company stock worth $5,931,934 in the last 90 days. Corporate insiders own 0.79% of the company’s stock.
Several research firms have recently weighed in on MON. Wells Fargo & Company upped their price objective on Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a research report on Tuesday, October 10th. Barclays PLC reaffirmed an “equal weight” rating and set a $124.00 price objective (up from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. BMO Capital Markets reaffirmed a “buy” rating and set a $128.00 price objective on shares of Monsanto in a research report on Thursday, October 5th. Macquarie cut Monsanto from an “outperform” rating to a “neutral” rating in a research report on Wednesday, October 4th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and set a $128.00 price objective on shares of Monsanto in a research report on Friday, September 15th. Eleven analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Monsanto presently has a consensus rating of “Hold” and an average target price of $124.61.
Monsanto Company (NYSE MON) traded up $0.96 during trading hours on Monday, reaching $118.30. The company’s stock had a trading volume of 2,329,700 shares, compared to its average volume of 1,937,834. The company has a quick ratio of 0.83, a current ratio of 1.35 and a debt-to-equity ratio of 1.12. The company has a market capitalization of $52,075.66, a price-to-earnings ratio of 21.39, a price-to-earnings-growth ratio of 1.70 and a beta of 1.05. Monsanto Company has a 12-month low of $97.35 and a 12-month high of $122.79.
Monsanto (NYSE:MON) last released its quarterly earnings data on Wednesday, October 4th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.41) by $0.61. The firm had revenue of $2.69 billion for the quarter, compared to analyst estimates of $2.51 billion. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The business’s revenue for the quarter was up 4.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.07 earnings per share. equities research analysts forecast that Monsanto Company will post 5.74 earnings per share for the current fiscal year.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.